EIR Sun Pharmaceutical Industries Jun 2019

Monica Burgos Garcia FDA, Kejun Cheng FDA, Rebecca Dombrowski FDA, Farhana Khan FDA$595.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries - Halol, India facility and issued inspectional observation (via FDA 483) on 11 Jun 2019.

Product details

  • Category:
  • Inspection end: 11 Jun 2019
  • Location: Halol, India
  • FEI: 3002809586
Add To Cart